Home Categories API 2,2-Dichloro-1,1-difluoroethyl methyl ether
F715923

2,2-Dichloro-1,1-difluoroethyl methyl ether , 97 , 76-38-0

Synonym(s):
2,2-Dichloro-1,1-difluoro-1-methoxyethane;hMOF;KAT8;MOF;MYST1

CAS NO.:76-38-0

Empirical Formula: C3H4Cl2F2O

Molecular Weight: 164.97

MDL number: MFCD00040144

EINECS: 200-956-0

Pack Size Price Stock Quantity
5g RMB2640.00 In Stock
25g RMB6056.00 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: -36°C
Boiling point: 103 °C
Density  1.4262
refractive index  1.386
Flash point: 37°C
storage temp.  -70°C
solubility  Chloroform (Sparingly)
form  liquid
color  Clear
Water Solubility  Miscible with alcohol, acetone, chloroform, ether, fixed oils and benzene. Immiscible with water.
Merck  14,5994
BRN  1737766
Exposure limits No exposure limit is set. Based on comparison with related compounds, a TLV-TWA of 675 mg/m3 (100 ppm) is recommended.
Stability: Stability
CAS DataBase Reference 76-38-0(CAS DataBase Reference)
EPA Substance Registry System Methoxyflurane (76-38-0)

Description and Uses

Methoxyflurane, 2,2-dichloro- 1,1- difluoro-1-methoxyethane,is a colorless liquid with a fruity odor. It is produced industrially by the addition of methanol to 1,1-dichloro- 2,2-difluoroethylene in the presence of sodium methoxide .

Methoxyflurane is used as a clinical anesthesia (inhalation).

Safety

Symbol(GHS) 
GHS02,GHS07
Signal word  Warning
Hazard statements  H226-H319-H341
Precautionary statements  P210-P241-P308+P311
Hazard Codes  Xi
Risk Statements  10
Safety Statements  23-24/25
RIDADR  3271
OEL Ceiling: 2 ppm (13.5 mg/m3) [60-minute] [*Note: REL for exposure to waste anesthetic gas.]
RTECS  KN7820000
Hazard Note  Irritant
HazardClass  3
PackingGroup  III
HS Code  2909191800
Hazardous Substances Data 76-38-0(Hazardous Substances Data)
Toxicity One of the most potent of the inhalational anesthetics, having a very high blood-gas partition coefficient and low vapor pressure at room temperature. Methoxyflurane is metabolized to a great extent (about 50-70%) in the liver and, as a consequence, there may be release of high concentrations of fluoride, sufficient to exceed the threshold for renal damage. Its use for sustained anesthesia is limited because of this renal toxicity and was discontinued around 1980.

RELATED PRODUCTS